BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Retina
,
Autoimmunity
,
Phenobarbital
,
rs2300478
,
EGFR
,
Response to oxidative stress
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
hepatocellular cancer
Summary
General Info
Curated Studies
Most Correlated Studies
Cholangiocarcinoma HuCCT1 cell line with WTAP overexpression
Cholangiocarcinoma HuCCT1 cells with YAP1[S127A] overexpression or YAP1 shRNA knockdown
Cholangiocarcinoma HuCCT1 cells overexpressing TEAD binding mutant YAP1 [S94A]
Natural killer and CD8 T cells from blood of HBV-associated hepatocellular carcinoma patients
Liver tumor cell lines from spontaneously transformed cholangiocytes (BDEsp cells)
Explore Curated Studies Results
Literature
Most Relevant Literature
Clinical value of identifying genes that inhibit hepatocellular carcinomas.
Diagnostic and Prognostic Value of miRNAs in Hepatoblastoma: A Systematic Review With Meta-Analysis.
LINC01023 Promotes the Hepatoblastoma Tumorigenesis via miR-378a-5p/WNT3 Axis.
Characterization of Hepatoma-Derived Growth Factor-Related Protein 2 Interactions with Heterochromat…
Association between lncRNA-H19 polymorphisms and hepatoblastoma risk in an ethic Chinese population.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Phase II Trial of Tivozanib in Advanced Hepatocellular Cancer
Assessment of Frailty in Patients With Advanced Hepatocellular Cancers
Sorafenib and TRC105 in Hepatocellular Cancer
Trial of Sorafenib in Hepatocellular Cancer (HCC) Transplant Patients
Treatment of Unresectable Hepatocellular Cancer With Opioid Growth Factor
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ